AMGN

SEC source: 0001127602-12-015263 · form4.xml · nonDerivative · entry 2

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,249

SEC source: 0001127602-12-015265 · form4.xml · nonDerivative · entry 2

SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,858

SEC source: 0001127602-12-015213 · form4.xml · derivative · entry 2

BALTIMORE DAVID · CIK 0001185858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015213 · form4.xml · nonDerivative · entry 1

BALTIMORE DAVID · CIK 0001185858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,526

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

SEC source: 0001127602-12-015215 · form4.xml · derivative · entry 2

BIONDI FRANK · CIK 0001032669 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015215 · form4.xml · nonDerivative · entry 1

BIONDI FRANK · CIK 0001032669 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,728

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 145 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015217 · form4.xml · derivative · entry 2

COFFMAN VANCE D · CIK 0001193998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015217 · form4.xml · nonDerivative · entry 1

COFFMAN VANCE D · CIK 0001193998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,676

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 92 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015219 · form4.xml · derivative · entry 2

de Carbonnel Francois · CIK 0001447121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015219 · form4.xml · nonDerivative · entry 1

de Carbonnel Francois · CIK 0001447121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,746

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 30 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015223 · form4.xml · derivative · entry 2

HENDERSON REBECCA M · CIK 0001254748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015223 · form4.xml · nonDerivative · entry 1

HENDERSON REBECCA M · CIK 0001254748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,960

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and will vest one year from the grant date because the director has less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 26 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015225 · form4.xml · derivative · entry 6

HERRINGER FRANK C · CIK 0001171694 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015225 · form4.xml · nonDerivative · entry 1

HERRINGER FRANK C · CIK 0001171694 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,093

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 165 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015229 · form4.xml · derivative · entry 2

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015229 · form4.xml · nonDerivative · entry 1

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,313

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 66 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015231 · form4.xml · derivative · entry 2

PELHAM JUDITH C · CIK 0001185287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015231 · form4.xml · nonDerivative · entry 1

PELHAM JUDITH C · CIK 0001185287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,304

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

SEC source: 0001127602-12-015233 · form4.xml · derivative · entry 2

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015233 · form4.xml · nonDerivative · entry 1

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,107

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 92 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015235 · form4.xml · derivative · entry 2

SCHAEFFER LEONARD D · CIK 0001016369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015235 · form4.xml · nonDerivative · entry 1

SCHAEFFER LEONARD D · CIK 0001016369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,300

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 45 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015237 · form4.xml · derivative · entry 2

SUGAR RONALD D · CIK 0001216519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2022-04-27

SEC source: 0001127602-12-015237 · form4.xml · nonDerivative · entry 1

SUGAR RONALD D · CIK 0001216519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,223

F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and will vest one year from the grant date because the director has less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

SEC source: 0001127602-12-015243 · form4.xml · nonDerivative · entry 1

BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,513

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 1

BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,454

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015247 · form4.xml · nonDerivative · entry 1

Bradway Robert A · CIK 0001396482 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,228

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,025

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015251 · form4.xml · nonDerivative · entry 1

Harper Sean E · CIK 0001541946 · EVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,911

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015253 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,227

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 17,753 RSUs which vest in one installment of 8,744 on 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal annual installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-015257 · form4.xml · nonDerivative · entry 1

MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,535

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015259 · form4.xml · nonDerivative · entry 1

Peacock Jonathan M · CIK 0001500241 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,027

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 75,000 RSUs which vest in three equal annual installments of 25,000 each commencing 10/28/2012; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-015261 · form4.xml · nonDerivative · entry 1

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,749

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015263 · form4.xml · nonDerivative · entry 1

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,433

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-015265 · form4.xml · nonDerivative · entry 1

SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,524

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

SEC source: 0001127602-12-014943 · form4.xml · nonDerivative · entry 1

BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,163

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 3

BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 63,914

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

SEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 2

BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,800

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 1

BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,443

SEC source: 0001127602-12-014948 · form4.xml · nonDerivative · entry 1

Bradway Robert A · CIK 0001396482 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,290

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014950 · form4.xml · nonDerivative · entry 1

Harper Sean E · CIK 0001541946 · EVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,257

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing on 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014953 · form4.xml · nonDerivative · entry 3

MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,069

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014953 · form4.xml · nonDerivative · entry 2

MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,725

SEC source: 0001127602-12-014953 · form4.xml · nonDerivative · entry 1

MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,225

SEC source: 0001127602-12-014957 · form4.xml · nonDerivative · entry 3

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust

Disclosed balance after: 8,407

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

SEC source: 0001127602-12-014957 · form4.xml · nonDerivative · entry 2

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,399

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 843 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 20,000 RSUs which fully vest on 10/28/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 1,306 shares of common stock acquired under the Company's Employee Stock Purchase Plan.

SEC source: 0001127602-12-014957 · form4.xml · nonDerivative · entry 1

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,172

SEC source: 0001127602-12-014960 · form4.xml · nonDerivative · entry 1

SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,383

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-014963 · form4.xml · derivative · entry 8

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,875

Underlying: Common Stock · 79,625 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-12-014963 · form4.xml · nonDerivative · entry 6

SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 145,362

F4 · price: The price reported is also an average price. The prices ranged from $70.63 to $71.08 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.